Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-09-05Clinical Trial Update: Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 Diabetes [Phase 3]
Phase 3 trial update evaluating inhaled pre-prandial human insulin for blood glucose control in type 2 diabetes; study terminated.
-
FDA approval · 2018-09-04FDA Approved: FIASP — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for FIASP (insulin aspart injection) from Novo Nordisk, authorizing changes to its labeling.
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: Evaluation of Evolocumab (AMG 145) Efficacy in Diabetic Adults With Hypercholesterolemia/Mixed Dyslipidemia [Phase 3]
Phase 3 trial evaluating evolocumab in diabetic adults with hypercholesterolemia or mixed dyslipidemia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: The Set-Point Study: Evaluating Effects of Changing Glucose Target on Bionic Pancreas Performance [NA]
ACompleted clinical trial evaluating the impact of changing glucose targets on the performance of a bionic pancreas system.
-
CLINICAL_TRIALS trial_result · 2018-08-29Clinical Trial Update: Dapagliflozin on Hyperlipidemia and Insulin Resistance in Type 2 Diabetic Patients (DAPHNIS Study) [Phase 4]
Phase 4 clinical trial investigating the effects of dapagliflozin on hyperlipidemia and insulin resistance in patients with type 2 diabetes.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-08-27Clinical Trial Update: Co-administration of Cabergoline and Gliclazide Improve Glycemic Parameters and Lipid Profile in T2DM Patients [Phase 3]
A Phase 3 trial update reports that co-administration of cabergoline and gliclazide improves glycemic parameters and lipid profile in patien…
-
CLINICAL_TRIALS trial_result · 2018-08-27Clinical Trial Update: Effect of DPP4 Inhibition on Vasoconstriction [Phase 4]
Phase 4 clinical trial assessing the effect of DPP4 inhibition on vasoconstriction in type 2 diabetes patients has completed with results po…
-
FDA approval · 2018-08-27FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (Laurus Labs Limited)
FDA approves Laurus Labs Limited's metformin hydrochloride as a generic drug under ANDA 209882.
-
CLINICAL_TRIALS trial_result · 2018-08-24Clinical Trial Update: A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy [Phase 2]
Phase 2 clinical trial update for investigational dulaglutide doses in adults with type 2 diabetes on metformin monotherapy; study completed…
-
CLINICAL_TRIALS trial_result · 2018-08-22Clinical Trial Update: The Efficacy and Safety of CKD-501 Added to D150 Plus D759 Therapy in Patients With Type 2 Diabetes [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of CKD-501 added to D150 Plus D759 therapy in patients with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2018-08-22Clinical Trial Update: Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction With Type 2 Diabetes Mellitus Study [Phase 4]
Phase 4 trial update investigating teneligliptin for progressive left ventricular diastolic dysfunction in type 2 diabetes mellitus patients…
-
CLINICAL_TRIALS trial_result · 2018-08-17Clinical Trial Update: Comparison of Premixed Insulin With Basal-plus Insulin in Type 2 Diabetes Patients [Phase 4]
Phase 4 clinical trial comparing premixed insulin with Basal-plus insulin in type 2 diabetes patients has completed.
-
CLINICAL_TRIALS trial_result · 2018-08-17Clinical Trial Update: Ketogenic Diet Treatment of Obesity With Co-morbid Type 2 Diabetes Mellitus and/or Obstructive Sleep Apnea [Phase 2]
Phase 2 trial investigating ketogenic diet for obesity with co-morbid type 2 diabetes mellitus and/or obstructive sleep apnea.
-
CLINICAL_TRIALS trial_result · 2018-08-17Clinical Trial Update: Technology-assisted Case Management in Adults With Type 2 Diabetes [NA]
A completed clinical trial evaluating technology-assisted case management for adults with Type 2 diabetes, with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-16Clinical Trial Update: Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Teneligliptin) [Phase 3]
A Phase 3 confirmatory trial evaluating MT-2412 as an add-on to Teneligliptin in Japanese patients with Type 2 Diabetes Mellitus has complet…
-
CLINICAL_TRIALS trial_result · 2018-08-16Clinical Trial Update: Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Canagliflozin) [Phase 3]
Tanabe's MT-2412 was studied as an add-on to canagliflozin in Japanese adults with type 2 diabetes in a Phase 3 confirmatory trial; results …
-
CLINICAL_TRIALS trial_result · 2018-08-16Clinical Trial Update: Long-Term Safety Study of MT-2412 in Japanese Patients With Type 2 Diabetes [Phase 3]
A Phase 3 long-term safety study of MT-2412 in Japanese patients with Type 2 Diabetes Mellitus has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2018-08-16Clinical Trial Update: Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Pilot Study) [Phase 3]
Pilot Phase 3 trial investigating early intermittent intensive insulin therapy as an effective treatment for type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2018-08-15Clinical Trial Update: Effects of Empagliflozin on Cardiac Structure in Patients With Type 2 Diabetes [Phase 4]
Phase 4 clinical trial update investigating the effects of empagliflozin on cardiac structure in patients with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2018-08-15Clinical Trial Update: Effect of SGLT2 Inhibitor on Blood Glucose Profile in Type 2 Diabetic Patients Using Basal Insulin [Phase 4]
Phase 4 trial update studying the effect of an SGLT2 inhibitor on blood glucose profile in type 2 diabetes patients using basal insulin.
-
CLINICAL_TRIALS trial_result · 2018-08-14Clinical Trial Update: Evogliptin in Type 2 Diabetes Mellitus (EVOLUTION: EVOgLiptina no Diabetes Mellitus TIpO 2) [Phase 2]
Phase 2 trial update for evogliptin in type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2018-08-13Clinical Trial Update: A Phase 2 Dose-finding Study of TAK-272 in Participants With Type 2 Diabetes Mellitus and Microalbuminuria [Phase 2]
Phase 2 dose-finding study of TAK-272 in participants with type 2 diabetes mellitus and microalbuminuria completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-13Clinical Trial Update: Efficacy and Safety of CKD-501 Added to D150 Plus D745 25mg Therapy in Patients With Type 2 Diabetes [Phase 3]
Phase 3 trial evaluating CKD-501 added to D150 Plus D745 25mg therapy for type 2 diabetes; efficacy and safety data not provided in snippet.
-
FDA approval · 2018-08-10FDA Approved: GLUCOTROL XL — Supplemental Application (Roerig)
FDA approved a supplemental application for GLUCOTROL XL (glipizide) submitted by Roerig. The action concerns the extended-release formulati…
-
FDA approval · 2018-08-09FDA Approved: TRESIBA — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for TRESIBA insulin degludec (Novo Nordisk).